Duncan Odom
American research group leader
From Wikipedia, the free encyclopedia
Duncan T. Odom is a research division head at the German Cancer Research Center (DKFZ) in Heidelberg, and a University Professor at Heidelberg University. Previously he was a research group leader at the Cancer Research UK Cambridge Institute (CRUK CI) at the University of Cambridge (2006-2022)[3][8][6] and an associate faculty member at the Wellcome Trust Sanger Institute (2011-2018).[4]
Duncan T. Odom | |
|---|---|
| Born | Duncan Odom |
| Alma mater | |
| Awards |
|
| Scientific career | |
| Fields | |
| Institutions | |
| Thesis | The application of metallointercalators in recognition of and charge transport in nucleic acids (2001) |
| Doctoral advisor | Jacqueline Barton[5] |
| Other academic advisors | Richard A. Young[6] |
| Doctoral students | Christina Ernst[7] |
| Website | www |
Education
Odom was educated at the New College of Florida where he was awarded a Bachelor of Arts degree in Chemistry in 1995.[4] He continued his study at California Institute of Technology (Caltech) where he was awarded a PhD in chemistry for research on DNA-binding metallo-intercalators supervised by Jacqueline Barton.[6][5]
Career and research
After a period as a postdoctoral researcher[9] in genetics and genomics at the Whitehead Institute in Cambridge, Massachusetts with Richard A. Young,[4] he established his research group at the University of Cambridge in 2006.[6] His research investigates how transcription and transcriptional regulation vary during evolution, and its implications for diseases such as cancer, using high throughput biology methods to investigate genome evolution.[10][11][12][13] As of 2017[update], according to Google Scholar his most highly-cited papers have been published in Cell,[14] Chemical Reviews,[15] and Science.[16][17]
His research has been funded by the National Institute of Diabetes and Digestive and Kidney Diseases,[6] the Alfred P. Sloan Foundation, the European Research Council (ERC),[citation needed] the European Molecular Biology Organization (EMBO), the Wellcome Trust[18] and Cancer Research UK.[6] His former doctoral students include Christina Ernst.[7]
Awards and honours
Odom was awarded the Crick Lecture by the Royal Society in 2014[1][19] for his "pioneering work in the field of comparative functional genomics, which has changed our understanding of the evolution of mammalian transcriptional regulation."[1] He was awarded EMBO Membership in 2015,[2] and the Mary F. Lyon Medal from The Genetics Society in 2016.[20]
